CEO extends $2.9M loan maturity to March 2023 at 4.5% interest

International Stem Cell CORP

On Sep 15, 2022, International Stem Cell Corp. extended maturity of $2.9M loan from CEO Andrey Semechkin to Mar 15, 2023.
The loan originally issued Mar 1, 2022 was due Sep 15, 2022; replaced with new unsecured, non-convertible note.
Interest rate remains 4.5% per annum; company may prepay without penalty.
Dr. Semechkin is Co-Chairman and CEO; transaction is a related-party extension.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.